Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isatuximab plus Pomalidomide and Dexamethasone in AL Amyloidosis
NCT05066607Phase 2Recruiting
- Start
- Feb 2022
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
A Phase 2 trial of isatuximab in amyloid light chain amyloidosis. Started Feb 2022; status: recruiting.
02
Drugs
isatuximab
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT05066607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05066607.